CMS unleashes innovation to ensure older adults have access to the latest advancements

A new final rule from CMS propels innovative technology so Medicare beneficiaries have access to the latest, most advanced devices. Under the Medicare Coverage of Innovative Technology final rule, the nation’s more than 60 million Medicare beneficiaries will have access to the latest technology even faster than ever. “Government processes have slowed beneficiaries’ access to innovative treatments. Despite being deemed safe and effective by the FDA, Medicare beneficiaries have not had predictable, immediate access to innovative breakthrough devices,” said CMS Administrator Seema Verma. The rule will eliminate lag time for older adults and innovators, creating a new, accelerated Medicare coverage pathway for innovative products deemed as “breakthrough” by FDA. The rule enables Medicare to provide national coverage simultaneously with FDA approval, for a period of up to 4 years. When the coverage period is over, CMS will reevaluate the device based on clinical and real-world evidence to determine more permanent coverage.